These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15840858)

  • 1. Erythropoietin and cancer.
    Sadoff L
    JAMA; 2005 Apr; 293(15):1858; author reply 1858-9. PubMed ID: 15840858
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin: high profile, high scrutiny.
    Crawford J
    J Clin Oncol; 2007 Mar; 25(9):1021-3. PubMed ID: 17312331
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human erythropoietin in children with cancer.
    MacMillan ML; Freedman MH
    J Pediatr Hematol Oncol; 1998; 20(3):187-9. PubMed ID: 9628427
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies to optimize the use of erythropoietin and iron therapy in oncology patients.
    Ford PA; Mastoris J
    Transfusion; 2004 Dec; 44(12 Suppl):15S-25S. PubMed ID: 15585001
    [No Abstract]   [Full Text] [Related]  

  • 5. Controversial effect of epoetin in cancer: grounds for a translational research exercise?
    Apolone G
    Eur J Cancer; 2004 Jun; 40(9):1289-91. PubMed ID: 15177486
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin, the FDA, and oncology.
    Steinbrook R
    N Engl J Med; 2007 Jun; 356(24):2448-51. PubMed ID: 17568025
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
    Anand A; Anand A; Anand N
    Cancer; 1996 May; 77(9):1960-1. PubMed ID: 8646701
    [No Abstract]   [Full Text] [Related]  

  • 8. New oversight put in place for physicians giving anemia drugs to patients with cancer.
    Mitka M
    JAMA; 2010 Apr; 303(14):1355-6. PubMed ID: 20388885
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical application of recombinant erythropoietin in anemic cancer patients.
    Henry DH
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia.
    Kara O; Dizdar O; Altundag K
    JAMA; 2008 Dec; 300(24):2855; author reply 2855-7. PubMed ID: 19109113
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of patients with anemia of malignancy with recombinant human erythropoietin.
    Herrmann F; Oster W; Mertelsmann R
    Contrib Nephrol; 1991; 88():238-45; discussion 246-7. PubMed ID: 2040185
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant human erythropoietin in the treatment of cancer.
    Stilgenbauer F; Egerer G; Karthaus M; Goldschmidt H; Ho AD
    Antibiot Chemother (1971); 2000; 50():106-14. PubMed ID: 10874459
    [No Abstract]   [Full Text] [Related]  

  • 13. [Erythropoietin to treat anemia in cancer patients].
    Delgado-Macías MT
    Med Clin (Barc); 2005 Dec; 125(20):796. PubMed ID: 16373035
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concern about the safety of erythropoietin in cancer patients].
    van der Lelie J
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):920-2. PubMed ID: 18561786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
    Vaupel P; Dunst J; Engert A; Fandrey J; Feyer P; Freund M; Jelkmann W
    Onkologie; 2005 Apr; 28(4):216-21. PubMed ID: 15840971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin-stimulating agents: new data yield new insights.
    Zitella L
    Oncology (Williston Park); 2007 Oct; 21(11 Suppl Nurse Ed):36-8. PubMed ID: 18154208
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of erythropoietin in the treatment of patients with oncohematological diseases].
    Lysenko DA; Lutsenko OM
    Lik Sprava; 2005 Jun; (4):69-75. PubMed ID: 16158722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of erythropoietin in the treatment of cancer-related anemia].
    Huang JX; Meng FJ
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: is it still a reasonable option or too dangerous?
    Rades D
    Oral Oncol; 2009 Feb; 45(2):91-3. PubMed ID: 18490191
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of renal anemia using synthetic human erythropoietin].
    Blumberg A; Zehnder C
    Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.